CDK8-IN-3
CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7.
Product Specifications
CAS Number
[1884500-15-5]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/CDK8-IN-3.html
Purity
98.17
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(NCCOC)C1=CC=C2C(C(CC3=CC=C(C4=CN(C)N=C4)C=C3)=NN2)=C1
Molecular Formula
C22H23N5O2
Molecular Weight
389.45
References & Citations
[1]Kai S, et al. Preparation of substituted indazoles as CDK8 inhibitors for treatment of proliferative diseases. WO 2016041618 A1 20160324
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![1H-Pyrrolo[2,3-c]pyridine-2,3-dione Monohydrate](https://cdn.genprice.uk/products/572/6115654866531/imageurl/trc-p903716-10mg.webp)
